Research study of 18-FLT (18F-3'-fluoro-3-deoxy-L-thymidine) positron emission tomography (PET/CT) sequential imaging to quantify tumour proliferation during radical radiotherapy in patients with non-small cell lung cancers and head and neck cancers

Guy's and St. Thomas' NHS Foundation Trust (UK)0 个研究点目标入组 20 人开始时间: 2010年7月27日最近更新: 2017年10月9日

适应症

试验速览

暂无简介。

•1. About to undergo radical radiotherapy for one of the following:
•1.1. Non-small cell lung cancer with staging between I - III and either the primary tumour or an involved lymph node being greater than 3 cm in maximum dimension
•1.2. Squamous cell carcinoma of the head and neck region with staging between II - IVA and either the primary tumour or an involved lymph node being greater than 3 cm in maximum dimension
•2. Over 18 years of age, either sex
•3. Able to understand consent form
•4. Fit for extra incovenience of longer stays in hospital on days of scans
•5. Receiving chemotherapy concurrently with radiotherapy

•1. Patient unfit to attend extra scanning visits
•2. Tumour criteria not met
•3. Clotting disorder for head and neck group
•4. Severe claustrophobia or inability to tolerate PET/CT
•5. Unable to provide written consent
•6. Pregnant or breastfeeding women
•7. Subjects taking nucleoside analog medications such as those used as antiretroviral agents

发起方

Guy's and St. Thomas' NHS Foundation Trust (UK)